Human conglutinin
US4906734A · kind A · utility
6Cited by
5References
1Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 8, 1986 |
| Grant date | Mar 6, 1990 |
| Priority date | — |
| Expiry date | Dec 8, 2006 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/831
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Human conglutinin, polyclonal, and monoclonal antibodies raised against human conglutinin, and their uses in therapy and diagnosis are described. Human conglutinin was obtained from human plasma by affinity chromatography with anti-bovine conglutinin antibody, has a relative molecular weight of 330 and 40 K unreduced and 66 K reduced as measured by SDS-PAGE, shows calcium-dependent and sugar inhibitable binding to complement-reacted immune complexes and zymosan, and immunological cross-reaction with anti-bovine conglutinin antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.